US based biotechnology company appoints BRC

US based biotechnology company appoints BRC

What’s new? A global US corporation, involved in the development and manufacture of therapies to combat serious neurological, autoimmune and rare diseases, approached BRC with a view to exploring the benefits of a best market practice review of its UK based...